Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
about
Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and DiseaseOrai1-dependent calcium entry promotes skeletal muscle growth and limits fatiguePore dynamics and conductance of RyR1 transmembrane domain.Protein-Energy Malnutrition Causes Deficits in Motor Function in Adult Male Rats.Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy.Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutantsMild Clinical Features and Histopathologically Atypical Cores in Two Korean Families with Central Core Disease Harboring RYR1 Mutations at the C-Terminal RegionBilayer measurement of endoplasmic reticulum Ca2+ channels.The couplonopathies: A comparative approach to a class of diseases of skeletal and cardiac muscle.Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damageThe effect of Astym® Therapy on muscle strength: a blinded, randomized, clinically controlled trial.Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 Protein.A chemical chaperone improves muscle function in mice with a RyR1 mutation.The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal.The disorders of the calcium release unit of skeletal muscles: what have we learned from mouse models?Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.Potassium dependent rescue of a myopathy with core-like structures in mouse.Excitation-Contraction Coupling Alterations in Myopathies.Role of Mitofusin-2 in mitochondrial localization and calcium uptake in skeletal muscle.A novel ratiometric emission probe for Ca2+ in living cells.Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.Inositol trisphosphate receptor-mediated Ca2+ signalling stimulates mitochondrial function and gene expression in core myopathy patients.
P2860
Q26770423-B7B0E0CB-5F1D-4416-9A8E-C09288D9CE2CQ30560181-F0913F56-9E93-45DC-B93D-B966B34C3AE8Q33736633-580A8579-1DD3-4790-9642-27D1A55ECD95Q33793634-6D1DDBD4-6522-4BFA-8542-DF6E64C52973Q34478102-10F1F8AF-459F-4D8A-8F32-6561083EC477Q34545457-7238702E-920D-4E8B-B814-978A477C216FQ34996571-8300ADE8-33BA-4CEC-AB6E-ED8205595A89Q35049794-5EDEAE06-4EAD-4DC5-9A3F-5C80FAC670CDQ35642611-BEC98E5E-33DA-4796-AB49-0D306EC6D8AFQ35673620-C07694CC-132A-421D-9D30-399EF4C96921Q35787753-4738193C-3FF4-4BED-90C0-5210200BFD84Q35824818-D02BFA82-F361-4BF6-9482-BF7F49B89B6BQ36586052-E8F4F332-E15C-486D-91D3-4381D32D8B51Q37589625-C30C40EA-BF20-4AA2-A812-B59A4C9775B5Q37733865-EB93EA0A-E116-4162-A33D-F5895FC97B0CQ38080810-01153F3E-06FE-4A60-B904-0F6AEE1B7534Q38271367-F6237ACD-FC37-4F00-8C30-36C0DD8083B4Q38329774-FC27B07A-7715-4D7F-898C-2A3C0320B0B1Q38749268-5371C8E6-BC71-4B9B-A224-2FF97D2CBBF4Q39493236-39559921-E070-4EAE-ACCC-871BB02B0F5CQ41955529-9A3EB034-22EB-41CD-8B97-BC1A71C9DD1EQ42046918-0D0FC39A-E63E-4130-A039-79AC4A37428BQ42132203-9C58BBBC-B854-4D89-A45C-3CED85CB9CFCQ45774344-B9BCA7DB-E6A1-4543-83DE-CE184E4AA027Q50510755-80748263-58E8-48EF-A7B3-F108DEE34B6EQ55397765-CB1EC29C-2296-4779-ACCA-A8221980E1DD
P2860
Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@ast
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@en
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@nl
type
label
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@ast
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@en
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@nl
prefLabel
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@ast
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@en
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@nl
P2093
P2860
P356
P1476
Muscle weakness in Ryr1I4895T/ ...... om the sarcoplasmic reticulum.
@en
P2093
David H MacLennan
Elena Zvaritch
Gerhard Meissner
Murat Orynbayev
Robert T Dirksen
Ryan E Loy
Simona Apostol
Werner Melzer
Zoita Andronache
P2860
P356
10.1085/JGP.201010523
P577
2010-12-13T00:00:00Z